Not applicableStudy completedNCT03967951What this trial is testingCT Radiomic Features of Pancreatic Neuroendocrine NeoplasmsWho this might be right forPancreatic Neuroendocrine Tumor Francesco De Cobelli 70
Not applicableStudy completedNCT04753229What this trial is testingKi67 Proliferation Index of Pancreatic Neuroendocrine NeoplasiaWho this might be right forNeuroendocrine Tumors Institut Paoli-Calmettes 50
Large-scale testing (Phase 3)Looking for participantsNCT05477576What this trial is testingStudy of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA TherapyWho this might be right forGEP-NETGastroenteropancreatic Neuroendocrine TumorGastroenteropancreatic Neuroendocrine Tumor Disease+4 more RayzeBio, Inc. 338
Early research (Phase 1)Study completedNCT00581815What this trial is testingSpectroscopy With Surface Coils and DecouplingWho this might be right forAdrenal Cortical CancerBrain CancerBreast Cancer+16 more Memorial Sloan Kettering Cancer Center 582
Early research (Phase 1)Study completedNCT02166255What this trial is testingAPN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Study completedNCT01658943What this trial is testingSelumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With ChemotherapyWho this might be right forPancreatic Acinar Cell CarcinomaPancreatic Ductal AdenocarcinomaRecurrent Pancreatic Carcinoma+1 more National Cancer Institute (NCI) 137
Early research (Phase 1)WithdrawnNCT03682744What this trial is testingCAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)Who this might be right forPeritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+4 more Sorrento Therapeutics, Inc.
Not applicableStudy completedNCT02983500What this trial is testingPatient Reported Outcomes Registry in Patient With Cancer CachexiaWho this might be right forMetastatic Pancreatic CancerNSCLC, Metastatic iOMEDICO AG 253
Not applicableNo Longer AvailableNCT03554434What this trial is testingAn Expanded Access Program for AM0010 (Pegilodecakin)Who this might be right forMelanomaProstate CancerOvarian Cancer+6 more Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT03797326What this trial is testingEfficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)Who this might be right forAdvanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more Merck Sharp & Dohme LLC 611
Testing effectiveness (Phase 2)Study completedNCT00050349What this trial is testingEPO906 in Carcinoid and Other Neuroendocrine TumorsWho this might be right forCarcinoidNeuroendocrine Tumors Novartis Pharmaceuticals 33
Not applicableStudy completedNCT06384417What this trial is testingUsing an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2Who this might be right forBreast CancerLung CancerGenito-Urinary Cancer+6 more Milton S. Hershey Medical Center 30
Early research (Phase 1)Active Not RecruitingNCT05462717What this trial is testingDose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more Revolution Medicines, Inc. 222
Early research (Phase 1)Active Not RecruitingNCT05057715What this trial is testingHuCART-meso + VCN-01 in Pancreatic and Ovarian CancerWho this might be right forPancreatic CancerSerous Ovarian Cancer University of Pennsylvania 13
Testing effectiveness (Phase 2)UnknownNCT02587689What this trial is testingPhase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid TumorWho this might be right forHepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+1 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Not applicableStudy completedNCT00900094What this trial is testingUMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerWho this might be right forBreast CancerColorectal CancerEsophageal Cancer+4 more University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Ended earlyNCT03333486What this trial is testingFludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood CancerWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more Roswell Park Cancer Institute 31
Early research (Phase 1)Study completedNCT03096054What this trial is testingA Phase I Trial of LY3143921 Hydrate in Solid TumoursWho this might be right forColorectal CancerHigh Grade Serous Ovarian CancerNon Small-cell Lung Cancer (Squamous Cell Variant)+4 more Cancer Research UK 69
Testing effectiveness (Phase 2)Temporarily pausedNCT05419479What this trial is testingSwitch Maintenance in PancreaticWho this might be right forPancreatic CancerAdenocarcinoma of the PancreasSquamous Cell Carcinoma of Pancreas+1 more James Cleary, MD, PhD 46
Early research (Phase 1)Study completedNCT01286987What this trial is testingStudy of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsWho this might be right forAdvanced or Recurrent Solid TumorsBreast NeoplasmsOvarian Cancer, Epithelial+4 more Pfizer 113